Wei Fan, Lin Yang, Tang Danfeng, Liang Ying, Qin Shuangshuang
Guangxi Key Laboratory of Medicinal Resources Protection and Genetic Improvement, Guangxi Botanical Garden of Medicinal Plants, Nanning, China.
National Engineering Research Center for Southwest Endangered Medicinal Materials Resources Development, Guangxi Botanical Garden of Medicinal Plants, Nanning, China.
Front Plant Sci. 2025 Aug 18;16:1591427. doi: 10.3389/fpls.2025.1591427. eCollection 2025.
and , belonging to the genus , are ethnomedicinal plants that contain valuable medicinal and nutritional compounds. However, their medicinal materials are frequently confused in the Chinese medicinal materials market. Moreover, molecular genomic resources for this genus remain limited, which hinders phylogenetic studies. In this study, the complete chloroplast (cp) genomes of and were sequenced to enable genome comparison and phylogenetic analysis. Both cp genomes exhibited typical quadripartite structures, with genome sizes of 152,937 bp for and 153,033 bp for . Each genome consisted of a large single copy (LSC) region (83,594 and 83,701 bp, respectively), a small single copy (SSC) region (17,773 and 17,776 bp, respectively), and two inverted repeats (IR) regions (50,570 and 51,556 bp, respectively). A total of 129 genes were annotated in each cp genome, including 8 ribosomal RNAs, 83 protein-coding genes, and 37 transfer RNAs. Comparative analysis revealed that although the overall genome structure, codon usage bias, simple sequence repeats (SSRs), and dispersed repetitive sequences were relatively conserved between the two cp genomes, certain genomic variations were present. Specifically, 286 SNPs and 104 indels were identified, and showed the highest variability and could serve as potential DNA barcode regions. Furthermore, phylogenetic analysis supported a close evolutionary relationship between the genus and . Divergence time estimation suggested that and diverged approximately 0.26 million years ago (Mya). Finally, we successfully distinguished the two species using SSR markers. This study lays the foundation for enriching the molecular data and phylogenetic insights of this genus, as well as for the safe application of its medicinal materials.
[植物名称1]和[植物名称2]属于[属名]属,是含有珍贵药用和营养成分的民族药用植物。然而,它们的药材在中国药材市场上经常混淆。此外,该属的分子基因组资源仍然有限,这阻碍了系统发育研究。在本研究中,对[植物名称1]和[植物名称2]的完整叶绿体(cp)基因组进行了测序,以进行基因组比较和系统发育分析。两个cp基因组均呈现典型的四分体结构,[植物名称1]的基因组大小为152,937 bp,[植物名称2]的基因组大小为153,033 bp。每个基因组由一个大单拷贝(LSC)区域(分别为83,594和83,701 bp)、一个小单拷贝(SSC)区域(分别为17,773和17,776 bp)和两个反向重复(IR)区域(分别为50,570和51,556 bp)组成。每个cp基因组共注释了129个基因,包括8个核糖体RNA、83个蛋白质编码基因和37个转运RNA。比较分析表明,虽然两个cp基因组之间的整体基因组结构、密码子使用偏好、简单序列重复(SSR)和分散重复序列相对保守,但仍存在某些基因组变异。具体而言,鉴定出286个单核苷酸多态性(SNP)和104个插入缺失(indel),[植物名称2]表现出最高的变异性,可作为潜在的DNA条形码区域。此外,系统发育分析支持[属名]属与[另一属名]属之间存在密切的进化关系。分歧时间估计表明,[植物名称1]和[植物名称2]大约在26万年前(Mya)分化。最后,我们成功地使用SSR标记区分了这两个物种。本研究为丰富该属的分子数据和系统发育见解以及其药材的安全应用奠定了基础。